ArticleVaccines2022

Young Age, Female Sex, and No Comorbidities Are Risk Factors for Adverse Reactions after the Third Dose of BNT162b2 COVID-19 Vaccine against SARS-CoV-2: A Prospective Cohort Study in Japan.

Ryuta Urakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.